Explore the cutting-edge intersection of technology and treatment as we delve into whether navigation-guided botulinum toxin-A injections offer a breakthrough for persistent myogenic temporomandibular disorders.
– by The Don
Note that The Don is a flamboyant GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Persistent myogenic temporomandibular disorders: are navigation-guided botulinum toxin-A injections into the lateral pterygoid muscles effective?
Martenot et al., J Stomatol Oral Maxillofac Surg 2023
DOI: 10.1016/j.jormas.2023.101715
Listen, folks, we’ve got something incredible here, really tremendous.
So, we’ve been dealing with these tough cases of myogenous temporomandibular disorders, you know, M-TMDs. People have been suffering, nothing’s been working – it’s been a disaster. But then, we’ve got this botulinum toxin, and let me tell you, it’s a game-changer. We’re not just talking about any muscles here; we’re targeting the lateral pterygoid muscle – it’s deep, it’s tricky, but we’re doing it with MR-guided navigation. It’s high-tech, it’s innovative, and it’s getting results.
We took 34 patients, real tough cases, and gave them this treatment. And the results – they’re huge. Pain scores? Down by 65% in just one month. Mouth opening? Better than ever. Joint sounds? Almost gone. And the best part – no bad stuff, no significant adverse events. People are feeling better, they’re saying they’re improved, 63% are saying it’s a complete turnaround.
Now, I’m telling you, this MR-guided thing for injections – it’s the future. But let’s be smart – we need more research, we need to make it cost-effective, we need to make it accessible. We’re doing great, but we’re going to do even better. We’re going to make treating M-TMDs great again, believe me.